×
Choose Speciality

EXPLORE!

LOGIN

By signing up or signing in to eMediNexus, you consent to eMediNexus collecting and using your personal data in accordance with our Privacy Policy. I consent to receive medical updates and communications from eMediNexus, it's parent company IJCP and its industry partners.

KunXian Capsule for the Treatment of IgA Nephropathy

  763 Views

eMediNexus    30 May 2022

KunXian has been shown to be effective and safe for the treatment of IgA nephropathy. 

It demonstrated a dose-response effect in the reduction of proteinuria in patients with IgA nephropathy. 

Women of childbearing age; however, may be at the risk of ovarian failure after being treated with TwHF preparations; hence, it is contraindicated in them. 

Reference

Le WB, Shi JS, Ging SW, et al. Effectiveness and safety of KunXian capsule for the treatment of IgA nephropathy. BMC Nephrol. 2022;23(1):179.

To comment on this article,
create a free account.

Sign Up to instantly get access to 10000+ Articles & 1000+ Cases

Already registered?

Login Now

Most Popular Articles

News and Updates

eMediNexus provides latest updates on medical news, medical case studies from India. In-depth medical case studies and research designed for doctors and healthcare professionals.